1,8-Dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione

Catalog No.: 
ACLAQB024
CAS No.: 
481-72-1
Molecular Formula: 
C15H10O5
Molecular Weight: 
270.24
1,8-Dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$144.00In stockInquiry
100g97%$477.00In stockInquiry
500g97%$1906.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,8-Dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione
IUPAC Name1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione
MDL No.MFCD00017373
Molecular FormulaC15H10O5
Molecular Weight270.24
SMILESO=C1C2=C(C=CC=C2O)C(C3=CC(CO)=CC(O)=C13)=O
InChI KeyYDQWDHRMZQUTBA-UHFFFAOYSA-N
Synonym9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)- | Aloeemodin | Aloe-emodin | Aloe-emodin, analytical standard | Q-100526 | MLS000697563 | s2259 | CCG-208456 | SR-01000765772-3 | 3-(Hydroxymethyl)chrysazin | 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-h
CAS No.481-72-1
PubChem CID10207

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLAQB024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWXGS564 route compound structure diagram
    ACWXGS564478-43-3In Stock
  2. Then
  3. ACLAQB024 route product structure diagram
    ACLAQB024481-72-1In Stock
Inquiry

2. ACLAQB024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLAQB024 route product structure diagram
    ACLAQB024481-72-1In Stock
Inquiry

3. ACLAQB024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLAQB024 route product structure diagram
    ACLAQB024481-72-1In Stock
Inquiry

Comments (0)